David Berntsen, Golden-Golden Professor of Optometry at University of Houston (IMAGE)
Caption
University of Houston Professor David Berntsen, co-principal investigator on the $25 million grants, predicts that the atropine drops will reduce the proportion of children who become nearsighted.
Credit
University of Houston
Usage Restrictions
None
License
Original content